CLL Society’s Official Statement Concerning Prioritizing CLL (chronic lymphocytic leukemia) Patients When Triaging Care During the COVID-19 Pandemic

Take it with you! CLL Society’s Official COVID-19 Triage Statement

CLL Society has authored an Official Statement to help you help your healthcare providers understand CLL patients’ unique vulnerabilities to COVID-19 and our higher risks of serious complications.

This letter to your healthcare provider may help you be attended to faster, should you have any COVID-19 symptoms or worries or want early access to the SARS-CoV-2 vaccine.

COVID-19 concerns are topline in medical offices these days and the demands for care can overwhelm some medical facilities, so triaging who gets attention becomes a necessity. Likewise vaccine supplies will be limited at first and experts agree that we should be at top of list of those most vulnerable. Fax, email, or otherwise draw your provider’s attention to this letter!

The CLL Society is invested in your long life. Please invest in the long life of the CLL Society.

Donate Now

Dr. Koffman on COVID-19 Vaccines
November 30, 2020

Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer (chronic lymphocytic leukemia or CLL) patient.
November 13, 2020

Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis
November 10, 2020

Unmasking the Mystery
October 23, 2020

We’ve Got You Covered!
October 20, 2020

CLL Society’s Official Statement Concerning CLL (chronic lymphocytic leukemia) Patients Working and Traveling During the COVID-19 Pandemic (8/16/2020 update)
August 20, 2020